A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
Groundbreaking AI models are now deciphering plant DNA, treating genetic sequences like language. This innovation promises to revolutionise genomics and agriculture, offering unprecedented insights into plant biology and accelerating crop improvement for global food security.
Steven T. Reed, O.D., President of the American Optometric Association, discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults over 50, and the importance of early diagnosis and preventive care.
Amidst a stark rise in US syphilis cases, researchers have secured a $2.7 million NIH grant to develop the first comprehensive, rapid test for active infection that aims to deliver accurate results within 10 minutes.
Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
Cancer cells are masters of disguise, evading immune destruction through cunning mechanisms. Groundbreaking research reveals a novel tactic: mitochondrial transfer. Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour growth.
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient. Researchers identified a RUFY1-RET fusion, highlighting the need for advanced genetic testing to guide treatment strategies and combat evolving resistance.
The University of Würzburg has shed light on the intricate mechanisms of insulin production in fruit flies, revealing surprising parallels with human physiology. This study offers crucial insights into how insulin-producing cells respond to metabolic changes, with potential implications for understanding and treating diabetes.
Biocompatibility is a key challenge for medical implants. Researchers have engineered apatite nanoparticles with enhanced cell adhesion via pH-controlled synthesis. This breakthrough promises more effective implant coatings, improving integration and reducing inflammation.
A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
Lorna Rothery spoke to Heidi Rehm, Chair of the Global Alliance for Genomics and Health, about steps to harness quality genomic data to support disease detection and the importance of collaboration in this endeavour.
Stoyan Tchoukanov, EESC member and Rapporteur for the EESC opinion on Promoting autonomous and sustainable food production, shares with us strategies for the Common Agricultural Policy post-2027.
